申请人:STANDARD LLC
公开号:US20190241504A1
公开(公告)日:2019-08-08
The present disclosure provides novel compounds capable of functioning as Myoctye Enhancer Factor 2 (MEF2) modulators, as well as compositions, pharmaceutical formulations, methods of synthesis and kits. Also provided are methods of treating a condition regulatable by MEF2 and/or MEF2 cofactors using the compounds, compositions, pharmaceutical formulations, and kits provided herein.
本公开提供了能够作为肌肉细胞增强因子2(MEF2)调节剂发挥作用的新化合物,以及组合物、药物配方、合成方法和试剂盒。还提供了使用本文提供的化合物、组合物、药物配方和试剂盒治疗可通过MEF2和/或MEF2辅因子调节的疾病的方法。